Proposed Data Collection Submitted for Public Comment and Recommendations, 12194-12195 [2018-05594]
Download as PDF
<![CDATA[
12194
Federal Register / Vol. 83, No. 54 / Tuesday, March 20, 2018 / Notices
1600 Clifton Drive, Atlanta, GA 30331,
(404) 639–4796; HShoob@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–05578 Filed 3–19–18; 8:45 am]
[FR Doc. 2018–05576 Filed 3–19–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day–18–18JC; Docket No. CDC–2017–
0121]
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
daltland on DSKBBV9HB2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
GH18–002, Strengthening detection of
emerging infectious diseases in India;
GH18–005, Enhancing Capacity for
Strategic and Applied Research
Activities in Support of Control and
Elimination of Malaria and Neglected
Tropical Diseases.
Date: April 18, 2018.
Time: 9:00 a.m.–2:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC,
1600 Clifton Drive, Atlanta, GA 30331,
(404) 639–4796; HShoob@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
VerDate Sep<11>2014
19:08 Mar 19, 2018
Jkt 244001
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Women’s Health Needs Study:
The Health of U.S.-Resident Women
from Countries with Prevalent Female
Genital Mutilation/Cutting (FGM/C).
DATES: CDC must receive written
comments on or before May 21, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0121 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Women’s Health Needs Study: The
Health of U.S.-Resident Women from
Countries with Prevalent Female Genital
Mutilation/Cutting (FGM/C)—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\20MRN1.SGM
20MRN1
12195
Federal Register / Vol. 83, No. 54 / Tuesday, March 20, 2018 / Notices
Background and Brief Description
Female Genital Mutilation/Cutting
(FGM/C) is a practice common in many
countries in parts of Asia, Africa and the
Middle East that can have severe,
deleterious health consequences for
women and girls. Recent studies suggest
that more than 500,000 women and girls
in the United States may have been cut
or be at risk for FGM/C based on
whether women or their mothers are
from countries with high prevalence of
FGM/C. However, this estimate was
derived using indirect techniques that
do not account for the differing
characteristics of women in the country
of origin versus those who have
migrated to the United States, or any
other factors that are likely to affect the
prevalence of FGM/C. Additional major
knowledge gaps regarding FGM/C in the
United States include: The prevalence
of FGM/C in selected communities in
full-scale survey of the health
experiences and needs of women who
live in selected communities in the
United States with high concentrations
of residents from countries where FGM/
C is widely practiced. The pilot study
will be conducted during the first year
of this project and will be used to assess
the feasibility of sampling and
recruiting methods for a hard-to-reach
population on a sensitive topic. Based
on findings from the pilot, a change
request, including necessary
translations, will be submitted to
conduct the full study during the
second and third year of this project.
The full study is planned to be
implemented in up to five community
sites in the United States. The estimated
annualized burden over the three years
of this project is 311 hours.
There are no costs to respondents
other than their time to participate.
the United States with high
concentrations of residents from
countries where FGM/C is prevalent;
women’s attitudes about continuance of
the practice; and the health
characteristics and needs of women
living in the United States who have
experienced FGM/C or are at risk for
FGM/C.
This study aims to capture
information on women’s history of
FGM/C, their experiences with health
care services, and their attitudes about
continuation of the FGM/C practice.
Findings from this study will be used to
identify public health needs of women
and communities in the United States
that are affected by FGM/C, to formulate
public health strategies to meet
identified needs, and to inform
prevention efforts.
The proposed information collection
will include piloting and conducting a
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Women age 18 to 49 who were born in, or
whose mother was born in, an FGM/C practicing country.
Women age 18–49 who were born in, or whose
mother was born in, an FGM/C practicing
country.
Total ...............................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–05594 Filed 3–19–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
daltland on DSKBBV9HB2PROD with NOTICES
Proposed Information Collection
Activity; Comment Request
Title: Evaluation of Domestic Victims
of Human Trafficking Program
OMB No.: 0970–0487.
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS) is proposing data
collection as part of the study,
‘‘Evaluation of the Domestic Victims of
Human Trafficking (DVHT) Program.’’
This Notice addresses the cross-site
VerDate Sep<11>2014
19:08 Mar 19, 2018
Jkt 244001
Number of
respondents
Form name
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
WHNS Eligibility
Screener.
667
1
1/60
11
WHNS Questionnaire ...
400
1
45/60
300
.......................................
........................
........................
........................
311
process evaluation to be conducted with
the 13 FY 2016 DVHT projects that were
awarded 3-year cooperative agreements
by the Office of Trafficking in Persons
(OTIP). The intent of the DVHT Program
is to build, expand, and sustain
organizational and community capacity
to deliver trauma-informed, strengthbased, and victim-centered services for
domestic victims of severe forms of
human trafficking through coordinated
case management, a system of referrals
and the formation of community
partnerships.
The objective of the evaluation is to
describe the ways in which projects
achieve the goals of the DVHT Program
and examine types of models that serve
victims of human trafficking. Evaluation
questions are focused on understanding
project and service delivery models,
process, and implementation, including
partnership and collaboration
development; services offered to and
received by victims; strategies to
identify and engage survivors; ways
projects define and monitor program
successes and outcomes; and program
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
challenges, achievements, and lessons
learned. Information from the
evaluation will assist federal, state, and
community policymakers and funders
in making decisions about future
program models to serve domestic
victims of human trafficking, as well as
to refine evaluation strategies for future
programs targeting trafficking victims.
The evaluation of the DVHT Program
will document and describe projects’
implementation approaches, including
their service models and community
partnerships; services provided to
clients (i.e., victims of severe forms of
human trafficking); service delivery
practices; strategies to meet survivors’
immediate and long-term housing
needs; and approaches to engaging
survivors in program development and
service delivery.
Primary data for the evaluation will
be collected via surveys with project
directors, case managers, and projects’
key community partners; and semistructured qualitative interviews,
including telephone interviews with
project directors, in-person interviews
with select project staff, survivor
E:\FR\FM\20MRN1.SGM
20MRN1
]]>Agencies
[Federal Register Volume 83, Number 54 (Tuesday, March 20, 2018)]
[Notices]
[Pages 12194-12195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-18JC; Docket No. CDC-2017-0121]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Women's Health Needs Study: The
Health of U.S.-Resident Women from Countries with Prevalent Female
Genital Mutilation/Cutting (FGM/C).
DATES: CDC must receive written comments on or before May 21, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0121 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Women's Health Needs Study: The Health of U.S.-Resident Women from
Countries with Prevalent Female Genital Mutilation/Cutting (FGM/C)--
New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
[[Page 12195]]
Background and Brief Description
Female Genital Mutilation/Cutting (FGM/C) is a practice common in
many countries in parts of Asia, Africa and the Middle East that can
have severe, deleterious health consequences for women and girls.
Recent studies suggest that more than 500,000 women and girls in the
United States may have been cut or be at risk for FGM/C based on
whether women or their mothers are from countries with high prevalence
of FGM/C. However, this estimate was derived using indirect techniques
that do not account for the differing characteristics of women in the
country of origin versus those who have migrated to the United States,
or any other factors that are likely to affect the prevalence of FGM/C.
Additional major knowledge gaps regarding FGM/C in the United States
include: The prevalence of FGM/C in selected communities in the United
States with high concentrations of residents from countries where FGM/C
is prevalent; women's attitudes about continuance of the practice; and
the health characteristics and needs of women living in the United
States who have experienced FGM/C or are at risk for FGM/C.
This study aims to capture information on women's history of FGM/C,
their experiences with health care services, and their attitudes about
continuation of the FGM/C practice. Findings from this study will be
used to identify public health needs of women and communities in the
United States that are affected by FGM/C, to formulate public health
strategies to meet identified needs, and to inform prevention efforts.
The proposed information collection will include piloting and
conducting a full-scale survey of the health experiences and needs of
women who live in selected communities in the United States with high
concentrations of residents from countries where FGM/C is widely
practiced. The pilot study will be conducted during the first year of
this project and will be used to assess the feasibility of sampling and
recruiting methods for a hard-to-reach population on a sensitive topic.
Based on findings from the pilot, a change request, including necessary
translations, will be submitted to conduct the full study during the
second and third year of this project. The full study is planned to be
implemented in up to five community sites in the United States. The
estimated annualized burden over the three years of this project is 311
hours.
There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Women age 18 to 49 who were WHNS Eligibility 667 1 1/60 11
born in, or whose mother was Screener.
born in, an FGM/C practicing
country.
Women age 18-49 who were born WHNS 400 1 45/60 300
in, or whose mother was born Questionnaire.
in, an FGM/C practicing
country.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 311
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-05594 Filed 3-19-18; 8:45 am]
BILLING CODE 4163-18-P
